$62.76
-0.30[-0.48%]
At close: Apr 19
$62.76
0[0.00%]
After Hours: 4:00PM EDT
Nuvalent
(NASDAQ:NUVL)Latest News for Nuvalent Stock (NASDAQ:NUVL)
Nuvalent Stock (NASDAQ: NUVL)
Categories: All
Wednesday, April 17, 2024
Monday, April 08, 2024
Monday, April 01, 2024
Wednesday, March 06, 2024
Wednesday, February 28, 2024
Tuesday, February 27, 2024
Friday, February 23, 2024
Monday, January 08, 2024
Tuesday, November 14, 2023
- Recap: Nuvalent Q3 EarningsBenzinga Insights - Nov 14, 2023, 9:30AM
- Nuvalent Q3 EPS $(0.59) Misses $(0.58) Estimate; Net Proceeds Of $282M From Public Offering, Along With Cash, Cash Equivalents, And Marketable Securities Of $413.3M Is Expected To Extend Operating Runway Into 2027Benzinga Newsdesk - Nov 14, 2023, 6:38AM
Thursday, October 19, 2023
Friday, October 13, 2023
Friday, October 06, 2023
Thursday, October 05, 2023
- Nuvalent shares are trading higher after JP Morgan and BMO Capital analysts raised their price targets on the stock.Bill Haddad - Oct 5, 2023, 3:50PM
- Where Nuvalent Stands With AnalystsBenzinga Insights - Oct 5, 2023, 12:00PM
- JP Morgan Maintains Overweight on Nuvalent, Raises Price Target to $68Benzinga Newsdesk - Oct 5, 2023, 10:54AM
- BMO Capital Maintains Outperform on Nuvalent, Raises Price Target to $73Benzinga Newsdesk - Oct 5, 2023, 8:55AM
Wednesday, October 04, 2023
- Stifel Reiterates Buy on NuvalentBenzinga Newsdesk - Oct 4, 2023, 1:42PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Oct 4, 2023, 1:31PM
- Nuvalent Shares Resume TradeBenzinga Newsdesk - Oct 4, 2023, 12:30PM
- Nuvalent Announced Preliminary Phase 1 Dose-Escalation Data from ALKOVE-1 Trial Of NVL-655 Demonstrated Activity In Heavily Pre-Treated Patients With ALK-Positive NSCLC And ALK-Selective, TRK-Sparing Safety ProfileBenzinga Newsdesk - Oct 4, 2023, 12:24PM
- Nuvalent Shares Halted On Circuit Breaker To The Upside, Stock Now Up 27.5%Benzinga Newsdesk - Oct 4, 2023, 12:21PM
- Nuvalent Shares Move Higher On VolumeBenzinga Newsdesk - Oct 4, 2023, 12:19PM
Wednesday, September 27, 2023
- Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the MoldVandana Singh - Sep 27, 2023, 2:44PM
- Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023Benzinga Insights - Sep 27, 2023, 11:00AM
- Stifel Initiates Coverage On Nuvalent with Buy Rating, Announces Price Target of $65Benzinga Newsdesk - Sep 27, 2023, 4:51AM
Monday, September 18, 2023
- Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Sep 18, 2023, 1:25PM
- Canopy Growth, DocGo And Other Big Stocks Moving Lower On MondayLisa Levin - Sep 18, 2023, 11:08AM
- Nuvalent Will Present Preliminary Dose-escalation Data From Its Ongoing ALKOVE-1 Phase 1/2 Trial Of Nvl-655 At The 35th AACR-NCI-EORTC SymposiumBenzinga Newsdesk - Sep 18, 2023, 6:43AM
Thursday, August 10, 2023
Tuesday, August 08, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023Benzinga Insights - Aug 8, 2023, 11:00AM
- Expert Ratings for NuvalentBenzinga Insights - Aug 8, 2023, 10:00AM
- SVB Leerink Initiates Coverage On Nuvalent with Market Perform Rating, Maintains Price Target of $42Benzinga Newsdesk - Aug 8, 2023, 9:08AM